Skip to content
OpenCapital
Get started

Kiniksa Pharmaceuticals International, plc KNSA Gross margin

Gross margin at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
95.1%-0.2pp
Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
98.4%-0.2pp
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
86%-0.2pp
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
150%-15.6pp
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
89.4%-0.2pp
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
90.9%+2.5pp

Other financials

Income statement

See full
Revenue$214.3M+55.5%
Gross profit$193.5M+61.3%
Operating income$29.3M+121%
Net income$22.6M+165%
EPS (diluted)$0.27+145%

Balance sheet

See full
Cash & equivalents$190.0M+20.9%
Total debt$9.0M-9.0%
Total equity$605.7M+32.4%
Total assets$825.3M+37.7%

Cash flow

See full
Operating cash flow$50.2M+125%
CapEx$161.0K+62.6%
Free cash flow$50.0M+125%

Valuation

See full
Market cap$4.24B+128%
Enterprise value$4.06B+139%
P/E58×—
P/S5.6×+1.8×

Profitability

See full
Operating margin12.4%+10.2pp
Net margin9.7%+7.6pp
FCF margin21.8%+12.2pp

Returns & leverage

See full
Return on equity13.7%+11.3pp
Debt / equity0×0.0×
Current ratio3.8×+0.1×

Where this comes from

Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.

gross profit/total revenue=89.3%

Based on trailing twelve months.

The official record: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Kiniksa Pharmaceuticals International, plc's gross margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Kiniksa Pharmaceuticals International, plc's gross margin?
Kiniksa Pharmaceuticals International, plc (KNSA) reported gross margin of 89.3% in Q1 2026.
How has Kiniksa Pharmaceuticals International, plc's gross margin changed year-over-year?
Kiniksa Pharmaceuticals International, plc's gross margin increased by 4.1% year-over-year, from 85.8% to 89.3%.
What is the long-term trend for Kiniksa Pharmaceuticals International, plc's gross margin?
Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's gross margin has grown at a 3.8% compound annual growth rate (CAGR), from 76.4% to 88.5%.
What does gross margin mean?
Gross profit (revenue minus cost of revenue) as a percentage of revenue, on a trailing-twelve-month basis. Measures how much of each sales dollar survives the direct cost of producing the goods or services sold.